Literature DB >> 28642226

Measuring patient-reported outcomes (PROs/PROMs) in people with Achilles tendinopathy: how useful is the VISA-A?

Adrian Mallows1, Chris Littlewood2, Peter Malliaras3.   

Abstract

Entities:  

Keywords:  Achilles tendon; reliability and validity; tendinopathy

Mesh：

Year:  2017        PMID： 28642226     DOI： 10.1136/bjsports-2017-097531

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN： 0306-3674            Impact factor:   13.800


× No keyword cloud information.
  5 in total

1.  Development of the University of Wisconsin Running Injury and Recovery Index.

Authors:  Evan O Nelson; Michael Ryan; Erin AufderHeide; Bryan Heiderscheit
Journal:  J Orthop Sports Phys Ther       Date:  2019-08-03       Impact factor: 4.751

2.  Assessment of content validity and psychometric properties of VISA-A for Achilles tendinopathy.

Authors:  Jonathan Comins; Volkert Siersma; Christian Couppe; Rene B Svensson; Finn Johansen; Nikolaj M Malmgaard-Clausen; S Peter Magnusson
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

Review 3.  Evaluating lower limb tendinopathy with Victorian Institute of Sport Assessment (VISA) questionnaires: a systematic review shows very-low-quality evidence for their content and structural validity-part I.

Authors:  Vasileios Korakakis; Argyro Kotsifaki; Manos Stefanakis; Yiannis Sotiralis; Rod Whiteley; Kristian Thorborg
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-05-21       Impact factor: 4.114

4.  High-Volume Image-Guided Injections in Achilles and Patellar Tendinopathy in a Young Active Military Population: A Double-Blind Randomized Controlled Trial.

Authors:  Robert M Barker-Davies; Polly Baker; James Watson; Duncan Goodall; Patrick C Wheeler; Alastair M Nicol; Daniel T P Fong; Mark P Lewis; Alexander N Bennett
Journal:  Orthop J Sports Med       Date:  2022-04-08

5.  The Victorian Sports Assessment Institute-Achilles Tendinopathy Questionnaire (VISA-A): Chinese cross-cultural adaptation and psychometric validation.

Authors:  Xiaoxian Tu; Zhiyuan Tu; Wei Lin; Zhe Wu
Journal:  Health Qual Life Outcomes       Date:  2022-07-23       Impact factor: 3.077
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.